Blog

With many companies currently turning to R&D tax relief as a way to inject crucial cash back into their business, we've received many questions from clients on how Covid-19 might affect their R&D claims in the short and long term.

The 2020 Budget focuses on on the subject of innovation. The Chancellor has made it clear that the UK’s success in the global economy will be rooted in innovation and cutting-edge technology.

Remember WALL-E? The friendly and compassionate ‘Waste Allocation Load Lifter Earth-class’ robot on a mission to tidy up our desolate planet?

Island nations, such as the United Kingdom, are literally surrounded by renewable energy sources.

Fossil fuels, as an energy source, accounted for 79.7% of the world’s total energy consumption in 2015.

Researchers from Australia have recently developed a new proteomics (study of proteins) technique called ‘ubiquitin clipping’, in collaboration with scientists at the MRC Laboratory of molecular Biology in Cambridge, UK.

By the year 2050, two-thirds of the world’s population will live in cities.

In August 2018 Claire Lomas completed the Manchester marathon after 8 days, perhaps nothing astonishing you might say, but Claire, a former equestrian eventer, was paralysed from the waist down after a freak riding accident.

Every year, millions of people die from lack of medical treatment. According to the UN, 1.6 million died in 2015 as a result of malaria, tuberculosis and HIV-related illnesses.

Poo-powered cars? Algae electricity? Public transport running on kitchen-oil and congealed fat? These are only some of the biofuel alternatives currently being developed!

Many people nowadays walk around with devices tracking their every move. Smartwatches and dedicated fitness trackers allow users to measure many aspects of their daily life and fitness activity.

It is hoped that recent research into genome editing, which allows scientists to change an organism’s DNA at particular locations in the genome, will lead to the development of new ways to prevent and treat human diseases. However, these also raise ethical questions and concerns.